SCHEMBL7323892

SCHEMBL7323892

O=C(Cc1ccc(Cl)cc1)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ORAI1 Q96D31 3/20 0.71
TRPV1 Q8NER1 3/20 0.54
CRACR2A Q9BSW2 2/20 0.54
RXFP1 Q9HBX9 1/20 0.54
TRPC3 Q13507 2/20 0.53
TRPC1 P48995 1/20 0.53
STIM1 Q13586 1/20 0.53
MAPT P10636 3/20 0.52
MAPK13 O15264 1/20 0.52
MAPK12 P53778 1/20 0.52
MAPK11 Q15759 1/20 0.52
MAPK14 Q16539 1/20 0.52
TP53 P04637 3/20 0.52
TRPC5 Q9UL62 1/20 0.52
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327760 0.89 TRPV1 (0.62) ORAI1TRPV1RXFP1MAPK13MAPK12
SCHEMBL7321880 0.83 ORAI1 (1.00) ORAI1CRACR2ATRPC3TRPC1STIM1
SCHEMBL5208645 0.83 ORAI1 (1.00) ORAI1CRACR2ATRPC3TRPC1STIM1
SCHEMBL7319211 0.83 ORAI1 (0.54) ORAI1TRPV1CRACR2ATRPC3TRPC1
SCHEMBL7320587 0.82 ORAI1 (0.64) ORAI1CRACR2ATRPC3TRPC1STIM1
SCHEMBL7233105 0.80 ORAI1 (0.70) ORAI1CRACR2ATRPC3TRPC1STIM1
SCHEMBL7323920 0.80 ORAI1 (0.60) ORAI1CRACR2ATRPC3TRPC1STIM1
SCHEMBL7323936 0.79 ORAI1 (0.59) ORAI1CRACR2ATRPC3TRPC1STIM1
SCHEMBL7320744 0.78 ORAI1 (0.74) ORAI1CRACR2ATRPC3TRPC1STIM1
SCHEMBL7325234 0.78 ORAI1 (0.67) ORAI1CRACR2ATRPC3TRPC1STIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP claimed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 ORAI1 3522/4885TRPV1 4710/4885CRACR2A 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.